These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Landmark hormone replacement therapy study stopped after finding more harms than benefits. Rollins G Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323 [No Abstract] [Full Text] [Related]
7. [Hormone substitution therapy in menopause and risk of breast cancer]. Colin C Rev Fr Gynecol Obstet; 1991 Jan; 86(1):27-8. PubMed ID: 2068481 [TBL] [Abstract][Full Text] [Related]
8. [Hormone therapy and menopause]. Heutling D; Lehnert H Dtsch Med Wochenschr; 2005 Apr; 130(13):829-34. PubMed ID: 15789305 [No Abstract] [Full Text] [Related]
9. [Present status concerning hormone replacement therapy in menopause and the risk of breast cancer]. Lopes P J Gynecol Obstet Biol Reprod (Paris); 1998 Oct; 27(1 Suppl):12-6. PubMed ID: 9864684 [No Abstract] [Full Text] [Related]
10. [Menopause in women--hormonal replacement therapy]. Kulikowski M; Tomaszewska I Pol Tyg Lek; 1995 Nov; 50(44-47):5-9. PubMed ID: 8643429 [No Abstract] [Full Text] [Related]
11. The pharmacokinetics and efficacy of different estrogens are not equivalent. Ansbacher R Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470 [TBL] [Abstract][Full Text] [Related]
12. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy? Shulman LP J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108 [No Abstract] [Full Text] [Related]
13. Estrogen therapy of perimenopausal and postmenopausal patients. Magera BE; Amerson AB; Wilson E Am J Hosp Pharm; 1979 Aug; 36(8):1062-71. PubMed ID: 384786 [No Abstract] [Full Text] [Related]
14. [Menopause, hormonal replacement therapy, and coronary disease]. Gebara OC; Wajngarten M; Barretto AC; Bellotti G Arq Bras Cardiol; 1995 Apr; 64(4):355-8. PubMed ID: 7495396 [No Abstract] [Full Text] [Related]
15. Estrogen therapy during menopause and the treatment of osteoporosis. Noyes MA; Demmler RW Prim Care; 1990 Sep; 17(3):647-66. PubMed ID: 2236341 [TBL] [Abstract][Full Text] [Related]
16. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Banks E; Canfell K Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078 [TBL] [Abstract][Full Text] [Related]
17. Estrogen replacement therapy: current thinking and practice. DeFazio J; Speroff L Geriatrics; 1985 Nov; 40(11):32-7, 40-3, 47-8. PubMed ID: 4054632 [TBL] [Abstract][Full Text] [Related]
18. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis]. Brettes JP; Mathelin C Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474 [No Abstract] [Full Text] [Related]
19. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought. Speroff L Menopause; 2008; 15(2):393-400. PubMed ID: 17925662 [TBL] [Abstract][Full Text] [Related]